Phase
Condition
N/ATreatment
Placebo
EYU688
Clinical Study ID
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female, 18 - 60 years old (inclusive).
History or presence of fever (≥ 38°C). At least one of the following criteriaindicating dengue infection:
Nausea or vomiting.
Presence of rash, aches or pains including headache, muscle or joint pain.
Onset of fever ≤ 48 hours prior to treatment start.
Positive test on dengue fever.
Exclusion
Exclusion Criteria:
Participants with any of abnormalities of clinical laboratory parameters.
Usage of any anticoagulant drugs.
Current significant medical conditions or illness that the investigator considersshould exclude the participants, especially those that require continuation of othermedications likely to have an interaction with the study drug.
Pregnant or nursing (lactating) women.
Clinical signs and symptoms for severe dengue according to Dengue Guideline (WHO
- at screening.
Participants with any of the following abnormalities of clinical laboratoryparameters at screening:
Hemoglobin <12.0 g/dL in males; <11.0 g/dL in females
Hematocrit >52 % in males; >46 % in females
Absolute neutrophil count <1500/μL
Platelet count <80,000/mm3
Creatinine >165 μmol/L in males; >130 μmol/L in females
Serum creatine kinase > 600 U/L
ALT, AST levels more than 1.5X upper limit of normal (ULN)
Total bilirubin >24 μmol/L
Usage of PPIs (proton pump inhibitor) which could affect absorption of EYU688 due tostomach pH value increase up to 48 hours prior to screening.
Women of child-bearing potential, defined as all women physiologically capable ofbecoming pregnant, unless they are using highly effective methods of contraceptionduring dosing and for 4 days after stopping of investigational drug.
History or long-QT syndrome, or clinically significant ECG abnormalities, or any ofthe following ECG abnormalities at screening:
QTcF > 450 msec (males)
QTcF > 460 msec (females)
Other protocol-defined inclusion/exclusion criteria may apply.
Study Design
Study Description
Connect with a study center
Novartis Investigative Site
Manaus, Amazonas 69040-000
BrazilActive - Recruiting
Novartis Investigative Site
Manaus 3663517, Amazonas 3665361 69040-000
BrazilSite Not Available
Novartis Investigative Site
Brasilia, DF 71 635-580
BrazilSite Not Available
Novartis Investigative Site
Brasília, Federal District 71635-580
BrazilActive - Recruiting
Novartis Investigative Site
Brasília 3469058, Federal District 3463504 71635-580
BrazilSite Not Available
Novartis Investigative Site
Rio de Janeiro, Rio de Janeiro 21040-360
BrazilActive - Recruiting
Novartis Investigative Site
Rio de Janeiro 3451190, Rio de Janeiro 3451189 21040-360
BrazilSite Not Available
Novartis Investigative Site
Sorocaba, São Paulo 18040-425
BrazilActive - Recruiting
Novartis Investigative Site
Sorocaba 3447399, São Paulo 3448433 18040-425
BrazilSite Not Available
Novartis Investigative Site
Sao Jose Rio Preto, 15090 000
BrazilActive - Recruiting
Novartis Investigative Site
Sao Jose do Rio Preto, 15090 000
BrazilSite Not Available
Novartis Investigative Site
Sao Jose do Rio Preto, 15090 000
BrazilSite Not Available
Novartis Investigative Site
São José do Rio Preto 3448639, 15090 000
BrazilSite Not Available
Novartis Investigative Site
São Paulo 3448439, 15090 000
BrazilSite Not Available
Novartis Investigative Site
Barranquilla, Atlántico 080012
ColombiaActive - Recruiting
Novartis Investigative Site
Barranquilla 3689147, Atlántico 3689436 080012
ColombiaSite Not Available
Novartis Investigative Site
Bucaramanga, Santander Department 681017
ColombiaActive - Recruiting
Novartis Investigative Site
Bucaramanga 3688465, Santander Department 3668578 681017
ColombiaSite Not Available
Novartis Investigative Site
Cali, Valle del Cauca Department 760032
ColombiaActive - Recruiting
Novartis Investigative Site
Cali 3687925, Valle del Cauca Department 3666313 760032
ColombiaSite Not Available
Novartis Investigative Site
Santiago de Cali 3687925, Valle del Cauca Department 3666313 760032
ColombiaSite Not Available
Novartis Investigative Site
Belagavi, Karnataka 590010
IndiaActive - Recruiting
Novartis Investigative Site
Belagavi 1276533, Karnataka 1267701 590010
IndiaSite Not Available
Novartis Investigative Site
Mumbai, Maharashtra 400008
IndiaSite Not Available
Novartis Investigative Site
Pune, Maharashtra 411013
IndiaActive - Recruiting
Novartis Investigative Site
Mumbai 1275339, Maharashtra 1264418 400008
IndiaSite Not Available
Novartis Investigative Site
Pune 1259229, Maharashtra 1264418 411013
IndiaSite Not Available
Novartis Investigative Site
Jaipur, Rajasthan 302017
IndiaActive - Recruiting
Novartis Investigative Site
Jaipur 1269515, Rajasthan 1258899 302017
IndiaSite Not Available
Novartis Investigative Site
Chennai, Tamil Nadu 600113
IndiaActive - Recruiting
Novartis Investigative Site
Chennai 1264527, Tamil Nadu 1255053 600113
IndiaSite Not Available
Novartis Investigative Site
Kuantan, Pahang 25200
MalaysiaActive - Recruiting
Novartis Investigative Site
Kuantan 1735227, Pahang 1733042 25200
MalaysiaSite Not Available
Novartis Investigative Site
Ipoh, Perak 30450
MalaysiaActive - Recruiting
Novartis Investigative Site
Ipoh 1734634, Perak 1733041 30450
MalaysiaSite Not Available
Novartis Investigative Site
Seberang Jaya, Pulau Pinang 13700
MalaysiaActive - Recruiting
Novartis Investigative Site
Seberang Jaya 6823221, Pulau Pinang 1733047 13700
MalaysiaSite Not Available
Novartis Investigative Site
Miri, Sarawak 98000
MalaysiaActive - Recruiting
Novartis Investigative Site
Miri 1738050, Sarawak 1733038 98000
MalaysiaSite Not Available
Novartis Investigative Site
Kuala Selangor, 68000
MalaysiaActive - Recruiting
Novartis Investigative Site
Kuala Selangor 1732891, 68000
MalaysiaSite Not Available
Novartis Investigative Site
Singapore, S308433
SingaporeActive - Recruiting
Novartis Investigative Site
Singapore 1880252, S308433
SingaporeSite Not Available
Novartis Investigative Site
Hai Phong, 04250
VietnamSite Not Available
Novartis Investigative Site
Haiphong, 180000
VietnamActive - Recruiting
Novartis Investigative Site
Haiphong 1581298, 180000
VietnamSite Not Available
Novartis Investigative Site
Hanoi, 100000
VietnamActive - Recruiting
Novartis Investigative Site
Hanoi 1581130, 100000
VietnamSite Not Available
Novartis Investigative Site
Ho Chi Minh, 700000
VietnamSite Not Available
Novartis Investigative Site
Ho Chi Minh City, 700000
VietnamActive - Recruiting
Novartis Investigative Site
Ho Chi Minh City 1566083, 700000
VietnamSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.